How it works
Bookimed is free for patients – clinics pay us a commission, and you pay the clinic its own price with no markup. Five steps to your immunotherapy for breast cancer in Thailand:
Share your case
Tell us about your breast cancer and share your latest scans and test results.
Get treatment plans
Your coordinator finds clinics that match your needs and helps you choose. Your preferred clinics then send personalized treatment plans and quotes for you to compare.
Plan your trip
We set treatment dates that work for you and help arrange your flights and accommodation.
Visit the clinic
Treatment may take several trips to the clinic. The clinic team starts your immunotherapy for breast cancer on the first visit. We support you throughout your treatment.
Complete your treatment
Treatment usually takes 6–12 months and ends with your final infusion. Your coordinator stays in touch and helps arrange a follow-up if you need one.
Some clinics ask for a deposit. A $200 or €200 deposit paid through Bookimed comes off your clinic bill and is refundable up to 10 calendar days before your visit. A deposit paid to the clinic follows its own terms.
Immunotherapy for breast cancer Prices by Clinic in Thailand
Panacee Medical Center – Stem Cell & Cell Therapy Center
Get matched with the best doctors for Immunotherapy for breast cancer
Tell us about your needs — and get 3 tailored offers from top doctors for you.
Do you have any medical records related to your issue?
Direct prices from clinics
Free evaluation of your medical case
Free personal assistance 24/7
Thailand Immunotherapy for breast cancer overview
Cost and clinics
| Typical immunotherapy for breast cancer price in Thailand | Clinics | Accreditations | Cities |
|---|---|---|---|
| $5,900 / ฿200,600–$14,000 / ฿476,000 | 2 clinic | ISO, JCI, GHA | Bangkok |
The procedure
| Before the trip | Time in Thailand | Nights in hospital | Operation time per visit | Anesthesia | Back to desk work | Final result |
|---|---|---|---|---|---|---|
| Confirm receptor status and PD-L1 result and complete baseline tests and infection screening | 9–17 visits over about a year (first trip 1–3 days) | None (outpatient procedure) | 2–6 hours | None | 2–7 days | 6–12 months |
How much does a Immunotherapy for breast cancer cost in Thailand?
In Thailand, immunotherapy for breast cancer is estimated from $5,900 / ฿200,600 to $14,000 / ฿476,000. The final amount depends on the drug, number of treatment cycles, hospital tier, and required tests.
In Thailand, immunotherapy for breast cancer is estimated from $5,900 / ฿200,600 to $14,000 / ฿476,000. The final amount depends on the drug, number of treatment cycles, hospital tier, and required tests. In the US, this procedure costs $105,000 / ฿3,570,000 on average. Available data does not specify which services are included in a quoted price, so patients should confirm whether medication, tests, and consultations are covered.
- Drug choice. Newer checkpoint inhibitors, such as pembrolizumab, may cost more than older protocols.
- Treatment duration. Total cost rises with the number of prescribed cycles or doses.
- Hospital tier. Premier private hospitals in Bangkok may charge more than public or university-affiliated centers.
- Pre-treatment workup. Biomarker testing, biopsies, imaging, and side-effect management may add costs.
Bookimed Expert Insight. Hospital choice may shape access and coordination, not just the treatment setting. Bumrungrad International Hospital in Bangkok lists oncology among its specialties and serves over 1,000,000 patients annually. It also holds Joint Commission International (JCI) accreditation and offers 150+ interpreters. Patients comparing options can check whether estimates list drug, testing, and imaging charges separately. Clinic package details were not provided here.
| Thailand | Turkey | Austria | |
|---|---|---|---|
| Immunotherapy for breast cancer | from $5,900 / ฿200,600 | from $8,000 / ฿272,000 | ≈ $18,000 / ฿612,000 |
How to choose a Immunotherapy for breast cancer clinic in Thailand
For immunotherapy for breast cancer in Thailand, speak with the treating doctor, confirm who carries out the main treatment steps, ask about credentials and facility standards, then read patient reviews.
What to check
Open discussion
Arrange time with the treating doctor – ask them to review your history, options, and possible complications before you commit.Treatment responsibility
Confirm the doctor you meet personally carries out the main immunotherapy steps you need, rather than another team member.Credentials and facilities
Ask whether the doctor is licensed by the Medical Council of Thailand, and whether the hospital meets acceptable safety standards.Patient feedback
Read comments about the doctor, care, and trip, not just the score – ask for references from similar cases.
Discover Immunotherapy for breast cancer Clinics in Thailand
| Clinic Name | Patient Rating | About | Accreditations | Lead Doctor | Techniques |
|---|---|---|---|---|---|
| Bumrungrad International Hospital Bangkok | 4.6 (131 reviews) | Bumrungrad International Hospital specializes in oncology with a dedicated breast cancer immunotherapy program. Dr. Prakasit Chirappapha is an oncosurgeon specializing in breast cancer treatment, providing personalized immunotherapy approaches. The hospital serves over 1 million patients annually, with 50% being international patients from 190+ countries, ensuring a globally experienced team. | ISO, JCI, GHA | Colonoscopy, MRI of the spine cord | |
| Panacee Medical Center – Stem Cell & Cell Therapy Center Bangkok | 4.6 | Panacee Medical Center Cell Therapy is a private multi-specialty center in Bangkok. Its main specialties are cardiology, therapy, medical check-ups, and wellness retreats. The clinic treats 5,000 patients each year from across Asia, the USA, Canada, and Australia. Treats both adults and children, from check-ups to cardiac care. Wellness retreat programs available alongside standard medical services. Patients come from Arab League States, Asia, the USA, Canada, and Australia. | — | — | Immunotherapy for breast cancer, Thyroid function tests (including T3, T4, TSH) |
Our Doctors
View all Doctors
Prakasit Chirappapha
The doctor is an oncosurgeon specializing in the treatment of breast cancer. With extensive experience in oncological surgery, the doctor focuses on innovative surgical techniques and personalized patient care. The doctor has contributed to numerous clinical trials and research studies aimed at improving breast cancer treatment outcomes. The doctor is affiliated with leading medical institutions and has presented findings at international conferences, highlighting advancements in minimally invasive procedures.
Is a Immunotherapy for breast cancer right for you?
Our Immunotherapy for breast cancer techniques
Immunotherapy with chemotherapy before surgery is usually chosen when you have early high-risk triple-negative breast cancer, because immunotherapy is given with chemotherapy before surgery to shrink the tumor. Immunotherapy with chemotherapy for metastatic breast cancer suits you if you have PD-L1-positive metastatic triple-negative breast cancer, because immunotherapy may be combined with chemotherapy for metastatic or recurrent breast cancer.
Immunotherapy for breast cancer recovery timeline: what to expect week by week
You can usually fly home 1–3 days after infusion with your doctor’s approval, depending on infusion reactions and chemotherapy blood counts. You may need 2–7 days before returning to desk work, and fatigue can make part-time work easier. You may resume light exercise within 0–1 weeks, as tolerated, depending on fatigue and chemotherapy side effects. The final result is assessed after the neoadjuvant phase and surgery, within 6–12 months.
Infusion day
Your infusion usually takes 30–60 minutes, though it may take longer with chemotherapy, and staff monitor you for reactions. You may feel discomfort from the cannula, a small tube placed in a vein.
Days 1–7 after infusion
Fatigue, nausea, and mild flu-like symptoms may occur, mainly from chemotherapy. Avoid crowds if your blood counts are low. You may fly home 1–3 days after infusion with your doctor’s approval, depending on reactions and blood counts.
Months 1–12
Treatment cycles usually repeat every 3–6 weeks, and immune-related effects can appear at any time, even after treatment ends. Blood, thyroid, and liver tests are checked before each cycle. Ask your oncologist before starting any new medicine.
When to contact your clinic: Contact your clinic promptly for a new cough or shortness of breath, diarrhea more than four times daily, or yellow skin or eyes.
Is a Immunotherapy for breast cancer in Thailand safe?
Traveling to Thailand for a Immunotherapy for breast cancer
Immunotherapy for breast cancer in Thailand: Video Reviews from Bookimed Patients
Thailand Immunotherapy for breast cancer Reviews at Bookimed: Discover Patients' Insights
View allShare this content
Anna Leonova
FAQ about Immunotherapy for breast cancer in Thailand
Which immunotherapy drugs are approved and available for breast cancer in Thailand?
Thailand approves several immunotherapy drugs for breast cancer, primarily targeting Triple-Negative Breast Cancer (TNBC). Keytruda (pembrolizumab) and Tecentriq (atezolizumab) are widely available at JCI-accredited centers like Bumrungrad International Hospital. Most treatments require PD-L1 biomarker testing to confirm patient eligibility before starting therapy.
- Approved checkpoint inhibitors: Keytruda (pembrolizumab) is FDA-approved for high-risk early-stage and metastatic TNBC.
- Domestic biological drugs: Thailand produces Herdara, a Trastuzumab biosimilar for HER2-positive breast cancer.
- Available targeted therapies: Nerlynx (neratinib) and Perjeta (pertuzumab) are used for advanced HER2-positive cases.
- Access points: Specialized oncology departments in Bangkok serve over 1,000,000 international patients annually.
Bookimed Expert Insight: While immunotherapy costs between $5,900 and $14,000, patients often save 90% compared to US averages. Top-tier hospitals like Bumrungrad integrate AI and digital imaging to monitor real-time tumor response. This technological edge often leads to more precise dosing than smaller regional clinics.
Patient Consensus: Patients emphasize the necessity of confirmed PD-L1 status via biopsy before traveling. Many recommend joining local support groups to navigate hospital negotiations and ensure authentic drug sourcing.
What are the success rates and clinical benefits of breast-cancer immunotherapy?
Immunotherapy for breast cancer achieves success rates up to 64.8% in early-stage triple-negative cases when combined with chemotherapy. This treatment harnesses the immune system to improve survival, reduce recurrence risks by 37%, and provide durable disease control across high-risk tumor subtypes.
- Success in TNBC: Pathologic complete response reaches 64.8% for early-stage triple-negative breast cancer.
- Survival extension: Treatment significantly extends overall survival for patients with PD-L1-positive metastatic tumors.
- Recurrence reduction: Pre-operative immunotherapy reduces the risk of disease recurrence by approximately 37%.
- Long-term durability: Unlike chemotherapy, immunotherapy produces lasting responses that continue after the treatment ends.
Bookimed Expert Insight: While Thailand offers advanced JCI-accredited care at centers like Bumrungrad International Hospital, timing is the critical differentiator. Bookimed data shows that the highest success occurs when immunotherapy serves as a bridge to surgery. Patients starting treatment early often achieve higher pathologic complete response rates. Choosing a facility with integrated AI and digital imaging ensures more precise tracking of initial tumor shrinkage.
Patient Consensus: Patients emphasize that while initial tumor shrinkage is encouraging, consistent monitoring of thyroid and kidney function is vital. Most find the strongest benefits when checkpoint inhibitors are paired with traditional chemotherapy protocols.
What side effects or risks may occur with breast-cancer immunotherapy?
Immunotherapy for breast cancer triggers immune-related adverse events by causing the immune system to attack healthy tissues. Common reactions include severe fatigue, skin rashes, and joint pain. Precise monitoring at JCI-accredited facilities like Bumrungrad International Hospital helps manage rare risks like pneumonitis or thyroid dysfunction.
- Immune-related fatigue: Persistent exhaustion often exceeding typical chemotherapy-related tiredness during treatment cycles.
- Dermatological reactions: Itchy rashes, redness, or blisters frequently appearing within days of infusion.
- Endocrine dysfunction: Permanent thyroid or adrenal gland changes requiring lifelong hormone replacement medication.
- Organ inflammation: Rare but serious inflammation of the lungs, liver, or colon.
Bookimed Expert Insight: Thai oncology centers like Bumrungrad International leverage advanced EHRs to track subtle symptom patterns. This technological edge is vital because immunotherapy side effects often peak 14 days post-infusion. Our data shows patients prioritize these high-tech clinics to catch inflammatory markers early.
Patient Consensus: Patients report that joint pain can mimic arthritis and stress the importance of daily symptom tracking. Many suggest planning for reduced work hours as fatigue levels remain unpredictable for months.
Which are the top hospitals providing immunotherapy for breast cancer in Thailand?
Top Thai hospitals for breast cancer immunotherapy include Bumrungrad International Hospital, Wattanosoth Cancer Hospital, and King Chulalongkorn Memorial Hospital. These institutions offer advanced immune checkpoint inhibitors, dendritic cell therapy, and personalized vaccines within JCI-accredited facilities, ensuring international safety standards and access to cutting-edge clinical protocols.
- Bumrungrad International: Features the Horizon Regional Cancer Center, serving over 1 million patients annually.
- Wattanosoth Hospital: Thailand first private facility dedicated entirely to specialized, research-driven oncology care.
- King Chulalongkorn: Pioneered world-first dendritic cell immunotherapy treatments for advanced breast cancer patients.
- Samitivej Sukhumvit: Collaborates with Massachusetts General Hospital, providing patients access to global immunotherapy clinical trials.
Bookimed Expert Insight: While public hospitals like Siriraj offer lower-cost trials, Bumrungrad International remains the primary choice for international patients. With 50% of its volume coming from 190 countries, the hospital provides faster access to drugs like pembrolizumab. This bypasses the long waiting lists often found in public medical systems or home countries.
Patient Consensus: Patients value the speed of starting treatment in Thailand but recommend verifying PD-L1 status via teleconsult first. Many suggest budgeting for extra stay time to accommodate infusion schedules and potential thyroid-related side effects.
Last review: Nov 20, 2026

Yesim Yildirim — 20 years of experience Medical oncologist, ESMO certified
Have a question about Immunotherapy for breast cancer in Thailand?
Ask a Bookimed medical coordinator about prices, clinics, techniques or your case. Write to us in the messenger you already use.
- Direct prices from clinics
- Free evaluation of your medical case
- Free personal assistance 24/7
Ask your question in a messenger
Tap a messenger to open a chat with a Bookimed medical coordinator.
Free and without obligation · Terms of use · Privacy policy










